Yosuke Morimoto

Impact of loss of skeletal muscle mass within 6–12 months after gastrectomy and S1 adjuvant chemotherapy on the survival prognosis of elderly patients with gastric cancer

H. Sugita, K. Yamashita, S. Sakuramoto, 2022, Surgery Today.

Short‐term outcomes of robot‐assisted minimally invasive esophagectomy with extended lymphadenectomy for esophageal cancer compared with video‐assisted minimally invasive esophagectomy: A single‐center retrospective study

T. Tsuji, Y. Kitagawa, N. Wada, 2021, Asian journal of endoscopic surgery.

Tumor Burden Monitoring with Circulating Tumor DNA During Treatment in Patients with Esophageal Squamous Cell Carcinoma

H. Saya, Y. Kitagawa, H. Kawakubo, 2023, Annals of Surgical Oncology.

Performance of a deep learning-based identification system for esophageal cancer from CT images

Y. Sakakibara, M. Jinzaki, Y. Kitagawa, 2021, Esophagus.

ASO Author Reflections: Can Circulating Tumor DNA Guide Individualized Treatment for Patients with Esophageal Squamous Cell Carcinoma?

H. Saya, Y. Kitagawa, H. Kawakubo, 2023, Annals of Surgical Oncology.

Remnant gastritis in gastric cancer patients causes loss of muscle mass 6 months after gastrectomy: a retrospective cohort study of Helicobacter pylori infection.

H. Sugita, K. Yamashita, S. Sakuramoto, 2023, Surgery today.

Low incidence of postoperative infectious complications following laparoscopic distal gastrectomy for locally advanced gastric cancer in older adult patients above 75 years: Propensity score-matched comparison with open distal gastrectomy.

H. Sugita, S. Sakuramoto, Gen Ebara, 2024, Asian journal of endoscopic surgery.